US4042511000 - Common Stock

**HNI** gets a fundamental rating of **5** out of 10. The analysis compared the fundamentals against 80 industry peers in the **Commercial Services & Supplies** industry. **HNI** has an average financial health and profitability rating. **HNI** has a decent growth rate and is not valued too expensively.

In the past year **HNI** was profitable.

Each year in the past 5 years **HNI** has been profitable.

The **Return On Assets** of **HNI** (**2.13%**) is comparable to the rest of the industry.

The **Return On Invested Capital** of **HNI** (**7.96%**) is better than **76.25%** of its industry peers.

Measured over the past 3 years, the **Average Return On Invested Capital** for **HNI** is in line with the industry average of **9.01%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.13% | ||

ROE | 5.79% | ||

ROIC | 7.96% |

ROA(3y)5.24%

ROA(5y)6%

ROE(3y)12.45%

ROE(5y)14.57%

ROIC(3y)8.82%

ROIC(5y)10.23%

The **Operating Margin** of **HNI** (**6.44%**) is comparable to the rest of the industry.

In the last couple of years the **Operating Margin** of **HNI** has remained more or less at the same level.

With a decent **Gross Margin** value of **38.41%**, **HNI** is doing good in the industry, outperforming **73.75%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 6.44% | ||

PM (TTM) | 1.85% | ||

GM | 38.41% |

OM growth 3Y-9.36%

OM growth 5Y-0.25%

PM growth 3Y2.18%

PM growth 5Y4.92%

GM growth 3Y-1.26%

GM growth 5Y-0.17%

Compared to 5 years ago, **HNI** has less shares outstanding

The debt/assets ratio for **HNI** is higher compared to a year ago.

With a decent **Debt to FCF ratio** value of **4.15**, **HNI** is doing good in the industry, outperforming **73.75%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.68 | ||

Debt/FCF | 4.15 | ||

Altman-Z | 2.67 |

ROIC/WACC0.93

WACC8.59%

A Current Ratio of **1.14** indicates that **HNI** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.14 | ||

Quick Ratio | 0.68 |

The **Earnings Per Share** has grown by an nice **12.56%** over the past year.

Measured over the past 5 years, **HNI** shows a small growth in **Earnings Per Share**. The EPS has been growing by **2.14%** on average per year.

The **Revenue** has decreased by **-3.03%** in the past year.

Measured over the past years, **HNI** shows a small growth in **Revenue**. The Revenue has been growing by **1.65%** on average per year.

EPS 1Y (TTM)12.56%

EPS 3Y-5.32%

EPS 5Y2.14%

EPS growth Q2Q30.99%

Revenue 1Y (TTM)-3.03%

Revenue growth 3Y1.68%

Revenue growth 5Y1.65%

Revenue growth Q2Q18.84%

EPS Next Y-0.61%

EPS Next 2Y9.61%

EPS Next 3Y3.01%

EPS Next 5YN/A

Revenue Next Year5.01%

Revenue Next 2Y9.35%

Revenue Next 3Y1.01%

Revenue Next 5YN/A

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

A **Price/Earnings** ratio of **17.66** indicates a rather expensive valuation of **HNI**.

68.75% of the companies in the same industry are more expensive than **HNI**, based on the **Price/Earnings** ratio.

When comparing the **Price/Earnings** ratio of **HNI** to the average of the S&P500 Index (**24.81**), we can say **HNI** is valued slightly cheaper.

The **Price/Forward Earnings** ratio is **15.03**, which indicates a correct valuation of **HNI**.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 17.66 | ||

Fwd PE | 15.03 |

Based on the **Enterprise Value to EBITDA** ratio, **HNI** is valued a bit cheaper than the industry average as 66.25% of the companies are valued more expensively.

Based on the **Price/Free Cash Flow** ratio, **HNI** is valued a bit cheaper than 76.25% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 14.47 | ||

EV/EBITDA | 9.82 |

The decent profitability rating of **HNI** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)8.25

EPS Next 2Y9.61%

EPS Next 3Y3.01%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.28% |

The dividend of **HNI** has a limited annual growth rate of **5.42%**.

Dividend Growth(5Y)5.42%

Div Incr Years13

Div Non Decr Years20

DP132.4%

EPS Next 2Y9.61%

EPS Next 3Y3.01%

**HNI CORP**

NYSE:HNI (12/6/2023, 10:34:03 AM)

**39.555**

**-0.2 (-0.52%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.84B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.28% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 17.66 | ||

Fwd PE | 15.03 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)8.25

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.13% | ||

ROE | 5.79% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 6.44% | ||

PM (TTM) | 1.85% | ||

GM | 38.41% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.15

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.68 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.14 | ||

Quick Ratio | 0.68 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)12.56%

EPS 3Y-5.32%

EPS 5Y

EPS growth Q2Q

EPS Next Y-0.61%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-3.03%

Revenue growth 3Y1.68%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y